Thank you, Chairman Pitts, for holding this hearing to further the discussion about FDA's authority over drug compounding.
I commend him for his efforts, and look forward to continue working with my colleagues to reform drug compounding rules.
Our investigation highlighted several opportunities where the agency confronted a choice in dealing with NECC and its si...
It is very hard to legislate cultural change into a large federal agency.
Good morning. I convene this hearing of the Subcommittee on Oversight and Investigations entitled 'Cyber Espionage and t...
The ability to link attribution and detection to criminal penalties, including arrest warrants, including limitations on...
We will be examining the effectiveness and efficiency of BioWatch.
I still want to know, and we are going to continue to pursue this because it is an important issue.
Thank you, Mr. Bruce. And our hearts are with you and your family.
It is clear we are all dedicated to coming up with some answers, a solution.
When it comes to court-ordered inpatient or outpatient treatment, it is extremely important to note that unless a legal ...